The COVID-19 Pandemic – News and Features

To capture public sentiment towards government recommendations, a YouGov survey was commissioned and completed by 2,108 UK adults between the dates of 17th – 18th March 2020. Here's what the public think.

Vivli, the Center for Clinical Research Data, is launching a COVID-19 portal for sharing of completed interventional treatment trial data.

The FDA has issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test.

To further reduce the risk of transmission of COVID-19 and for the safety of staff, the National Institutes of Health (NIH) is shifting all non-mission-critical laboratory operations to a maintenance phase.

Early stage biotech company Aqualung Therapeutics is currently developing a therapeutic monoclonal antibody – ALT-100 – for the treatment of unchecked inflammation. COVID-19 can cause severe pneumonia and respiratory failure. There is therefore a potential option to treat patients diagnosed with COVID-19 with ALT-100. Technology Networks recently spoke with Joe Garcia, MD, Founder and Chief Executive Officer of Aqualung Therapeutics to learn more.

CEL-SCI Corporation recently announced that it is utilizing LEAPS peptide technology in efforts to develop an immunotherapy against the novel coronavirus caused by SARS-CoV-2. Technology Networks, spoke with Daniel Zimmerman, Ph.D. Senior VP of Research, Cellular Immunology at CEL-SCI Corporation, to learn more about the LEAPS technology.

Researchers from the University of Wisconsin Madison discuss the potential impacts of COVID-19 on the agricultural industry.

University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends.

Researchers are using a pioneering imaging technology—called Mango, for its bright color— to develop coronavirus testing kits.

Synthace joins the growing number of companies offering services for free to researchers working to overcome the coronavirus pandemic.